CytoNiche is revolutionizing the Cell and Gene Therapy (CGT) industry with our scalable 3D FloTrix technology, offering comprehensive solutions for CGT manufacturing. This innovation not only reduces production time and costs but also improves scalability, making it possible to produce billions of high-quality cells more efficiently than traditional methods. By reducing facility footprint, labor costs, and contamination risks, our technology is helping shape the future of sustainable biomanufacturing, bringing us closer to benefiting more patients around the world.

Our product portfolio includes GMP-grade dissolvable microcarriers, serum-free media for mesenchymal stromal/stem cells, and a complete suite of GMP-compliant equipment and consumables.
These solutions support every stage of cell production—from expansion and harvesting to processing and filling. Backed by extensive industry experience and supported by FDA Master Files, our core technology is already being used in several upcoming registered clinical trials, as well as in a successfully commercialized therapeutic.
Whether you're working with mesenchymal stem cells (MSCs), exosomes, or other future technologies based on adherent cells, our systems are designed to meet the growing demands of the CGT field.